TG Therapeutics Inc (TGTX) — Long-term Investment Intensity

Latest as of June 2026: 8.5%

TG Therapeutics Inc (TGTX) has a Long-term Investment Intensity of 8.5% as of June 2026. Long-term investments of $139.85 Million represent 8.5% of total assets of $1.64 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of TG Therapeutics Inc to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

8.5%
LT Investments / Total Assets

Long-term Investments

$139.85 Million
USD

Total Assets

$1.64 Billion
USD

Country

USA
NASDAQ

TG Therapeutics Inc Long-term Investment Intensity (2013–2025)

This chart shows how TG Therapeutics Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2025. As of June 2026, the intensity stands at 8.5%, reflecting long-term investments of $139.85 Million against total assets of $1.64 Billion USD. For the complete balance sheet picture, see TGTX total asset value.

Annual Long-term Investment Intensity for TG Therapeutics Inc (2013–2025)

The table below presents the year-by-year Long-term Investment Intensity for TG Therapeutics Inc from 2013 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read TG Therapeutics Inc debt and liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 7.0% $74.83 Million $1.06 Billion ▲ +6.9 pp
2024 0.1% $808.00K $577.69 Million ▼ -6.3 pp
2022 6.4% $12.40 Million $193.57 Million ▼ -3.0 pp
2021 9.4% $35.53 Million $379.63 Million ▼ -12.7 pp
2015 22.0% $25.00 Million $113.47 Million ▲ +11.8 pp
2013 10.2% $4.92 Million $48.11 Million
pp = percentage points